Crizocent 250 mg (Capsule)

Unit Price: ৳ 1,500.00 (3 x 4: ৳ 18,000.00)
Strip Price: ৳ 6,000.00

Medicine Details

Category Details
Generic Crizotinib
Company Incepta pharmaceuticals ltd

Title

  • Crizocent - Kinase Inhibitor for NSCLC Treatment

Categories

  • Medicine
  • Pharmacology
  • Oncology
  • Cancer Therapy

Description

  • First FDA-approved biomarker-driven therapy for ALK-positive and ROS1-positive metastatic NSCLC

Indications

  • Treatment of metastatic non-small cell lung cancer (NSCLC) with ALK-positive tumors
  • Treatment of metastatic NSCLC with ROS1-positive tumors

Pharmacology

  • Inhibitor of receptor tyrosine kinases including ALK, c-Met, ROS1, and RON
  • Demonstrated concentration-dependent inhibition of ALK, ROS1, and c-Met phosphorylation
  • Absorption: Peak concentration achieved in 4-6 hours
  • Distribution: Extensive tissue distribution with high plasma protein binding
  • Metabolism: Predominantly metabolized by CYP3A4/5
  • Elimination: Mean half-life of 42 hours

Dosage administration

  • Recommended Dose: 250 mg orally, twice daily
  • Geriatric Use: No safety or efficacy differences observed in older patients
  • Pediatric Dose: Safety and effectiveness not established for pediatric patients
  • Renal Impairment: 250 mg orally, once daily for severe renal impairment
  • Hepatic Impairment: Caution advised

Drug interaction

  • CYP3A Inhibitors: Concurrent use should be avoided
  • CYP3A Inducers: Concurrent use should be avoided
  • CYP3A Substrates: Concurrent use should be avoided

Side effects

  • Common adverse reactions include vision disorders, nausea, and diarrhea

Pregnancy lactation

  • Can cause fetal harm
  • Females of reproductive potential should use effective contraception
  • Patients should not breastfeed during treatment and for 45 days after the final dose

Precautions warnings

  • Periodic liver testing recommended
  • Permanently discontinue in patients with ILD/Pneumonitis
  • Monitor ECG and electrolytes in patients with QTc prolongation

Therapeutic class

  • Targeted Cancer Therapy

Storage conditions

  • Keep below 30°C, away from light and moisture

Related Brands